Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страница 1 от 19 резултата
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION
This invention relates to prevention and treatment of various infectious agents and in particular, relates to inhibitory activity of cellulose sulfate and other sulfated polysaccharides against various infectious agents, including papilloma virus and various vaginitis-causing
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FIELD OF THE INVENTION
This invention relates to prevention and treatment of various infectious agents and in particular, relates to inhibitory activity of cellulose sulfate and other sulfated polysaccharides against various infectious agents, including papilloma virus and various vaginitis-causing
Nutritional composition
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
TECHNICAL FIELD
The present invention relates to a nutrient composition (nutritional composition) having lipid metabolism-improving action. The nutrient composition highly effectively contributes to decrease of neutral lipids (triglycerides). The nutrient composition is expected to offer
Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
FEDERALLY SPONSORED RESEARCH STATEMENT
Not applicable.
FIELD OF THE INVENTION
The present invention relates to novel compositions for and methods of treating symptoms, syndromes, pathological conditions and disease-associated problems mediated by oxidative stress. These conditions include cancer,
Ondansetron orally disintegrating tablets
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to non-effervescent, solid dosage forms adapted for oral administration of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carb- azol-4-one (ondansetron) as an anti-emetic active
Recognins and their chemoreciprocals
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
THE INVENTION
This invention is directed to a novel group of compounds, herein termed Recognins. Recognins are made by treating normal or diseased cells or tissues, e.g. tumor cells or artificial cancer cells and separating the desired products. The Recognins may be used to prepare their
Compositions containing micronized tanaproget prepared by wet granulation
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
Micronized tanaproget and compositions containing the same are provided.
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family,
Compositions containing micronized tanaproget prepared by wet granulation
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
Micronized tanaproget and compositions containing the same are provided.
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family,
Micronized tanaproget, compositions, and methods of preparing the same
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Micronized tanaproget, compositions, and methods of preparing the same
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Micronized tanaproget, compositions, and methods of preparing the same
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Micronized tanaproget and compositions containing same
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
BACKGROUND OF THE INVENTION
Intracellular receptors (IR) form a class of structurally related gene regulators known as "ligand dependent transcription factors". The steroid receptor family is a subset of the IR family, including the progesterone receptor (PR), estrogen receptor (ER), androgen
Solid dosage forms of oleyl phosphocholine
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
The present invention relates to solid dosage forms of oleyl phosphocholine (C18:1-PC), or OlPC, for oral administration. Further, the present invention relates to methods for the preparation of the present solid dosage forms and the use thereof as a medicament and especially a medicament for the
Dosage forms having prolonged active ingredient release
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
RELATED APPLICATIONS
This is a National Stage of International Application Number PCT/CH02/00486, filed Sep. 4, 2002, which claims priority of EP patent application 01810865.4 filed Sep. 10, 2001.
FIELD OF THE INVENTION
The invention relates to solid, orally administrable pharmaceutical dosage forms
Extract of Lepidium meyenii roots for pharmaceutical applications
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
The present invention relates to compositions containing particular components that can be obtained from a plant which can have pharmaceutical applications. More particularly, the plant genus is Lepidium.
Lepidium meyenii, commonly called maca or Peruvian ginseng, is a perennial plant having a
Най-пълната база данни за лечебни билки, подкрепена от науката
- Работи на 55 езика
- Билкови лекове, подкрепени от науката
- Разпознаване на билки по изображение
- Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
- Прочетете научни публикации, свързани с вашето търсене
- Търсете лечебни билки по техните ефекти
- Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите
Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания
